Results 41 to 50 of about 9,240 (233)

«FLARES» IN AXIAL SPONDYLOARTHRITIS

Научно-практическая ревматология, 2016
The clear definition of the concept of «flare in axial spondyloarthritis» is of paramount importance for clinical trials and routine practice in particular.
Sh. F. Erdes
doaj   +1 more source

The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry

Therapeutic Advances in Musculoskeletal Disease, 2023
Background: The Ankylosing Spondylitis (AS) Disease Activity Score (ASDAS) is largely used for assessing disease activity in patients with AS. Objectives: We aimed to investigate the predictability of ASDAS on drug survival in patients with low Bath AS ...
Jinhyun Kim, Min Jung Kim, Geun Young Oh, Sun Kyung Lee, Taeeun Kim, Kichul Shin   +5 more
doaj   +1 more source

HLA-B27 is associated with reduced disease activity in axial spondyloarthritis

Scientific Reports, 2021
HLA-B27 is associated with increased susceptibility and disease activity of ankylosing spondylitis, but the effect of HLA-B27 on the activity of the broader category now called axial spondyloarthritis (AxSpA) is apparently the opposite.
James T. Rosenbaum, Michael H. Weisman, Hedley Hamilton, Cassie Shafer, Elin Aslanyan, Richard A. Howard, Kimberly Ogle, John D. Reveille, Kevin L. Winthrop, Dongseok Choi   +9 more
doaj   +1 more source

SAT0260 Eligibility criteria for tnfi therapy in axspa: going beyond basdai [PDF]

Annals of the Rheumatic Diseases, 2018
Background A BASDAI ≥4 has been often required to start TNFi therapy in patients with axSpA. However, this cut-off of high disease activity (HDA) is largely arbitrary. Unlike BASDAI, ASDAS incorporates objective measures (e.g. CRP) and has a validated definition of HDA (≥2.1). It has thus been suggested that ASDAS could also be used to guide treatment
J.A. Marona, A. Sepriano, S. Rodrigues-Manica, F. Pimentel-Santos, A.F. Mourão, N. Gouveia, J.C. Branco, F. Vinagre, R. Roque, J. Rovisco, M.L. Marques, J. Tavares-Costa, J. Silva, H. Santos, N. Madeira, E. Vieira-Sousa, R. Machado, M. Bernardes, R. Ferreira, S. Ramiro   +19 more
openaire   +1 more source

VASCULAR WALL STIFFNESS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF A MULTICENTER STUDY

Klinicist, 2015
Objective: to study some vascular wall stiffness parameters in patients with ankylosing spondylitis (AS) without clinically manifest cardio­ vascular diseases. Subjects and methods.
I. Z. Gaydukova, A. L. Maslyansky, O. L. Polyanskaya, E. P. Kolesova, A. P. Rebrov, A. O. Konradi   +5 more
doaj   +1 more source

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis [PDF]

Annals of the Rheumatic Diseases, 2004
TNFalpha blockers have been shown to be highly efficacious in patients with active ankylosing spondylitis (AS).To identify parameters predicting the clinical response to TNF blockers in AS.Patients with active AS participated in two placebo controlled, randomised trials conducted in Germany with infliximab (n = 69) and etanercept (n = 30), respectively.
Martín Rudwaleit, J Listing, J Brandt, J Braun, J Sieper   +4 more
openalex   +4 more sources

Evaluation of the Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index in Ankylosing Spondylitis Patients

İstanbul Medical Journal, 2023
Introduction: The aim of this study was to investigate the relationship between the Systemic Immune-Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) and disease activity in patients with ankylosing spondylitis (AS).
Burak Tayyip Dede, Berat Bulut, Muhammed Oğuz, Fatih Bağcıer, Ebru Aytekin   +4 more
doaj   +1 more source

GUIDELINES FOR THE ASSESSMENT OF DISEASE ACTIVITY AND FUNCTIONAL STATUS IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN CLINICAL PRACTICE

Научно-практическая ревматология, 2017
The paper gives the recommendations for the assessment of disease activity and functional status in patients with ankylosing spondylitis in clinical practice, which have been developed by experts, by taking into account international and Russian ...
T. V. Dubinina, I. Z. Gaidukova, A. A. Godzenko, S. A. Lapshina, A. P. Rebrov, O. A. Rumyantseva, V. V. Badokin, A. G. Bochkova, O. V. Bugrova, A. I. Dubikov, O. N. Ivanova, T. V. Korotaeva, O. B. Nesmeyanova, I. P. Nikishina, E. N. Otteva, T. A. Raskina, A. V. Smirnov, A. V. Sitalo, Sh. F. Erdes   +18 more
doaj   +1 more source

Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?

Arthritis Research & Therapy, 2023
Objectives To (i) determine whether sustained disease activity states, as measured by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS), impact function, and (ii) evaluate ...
Walter P. Maksymowych, Robert D. Inman, Louis Bessette, Proton Rahman, Emmanouil Rampakakis, Odalis Asin-Milan, Meagan Rachich, Anne Marilise Marrache, Allen J. Lehman   +8 more
doaj   +1 more source

E100 Comparison between BASDAI and ASDAS c-reactive protein scores in spondyloarthritis [PDF]

Rheumatology
Abstract Background/Aims The choice between evaluation indices for disease activity in spondyloarthritis (SpA) in daily practice can be challenging due to the highly heterogeneous clinical expression of the disease.
Mohammed Khalil Jnyah, Imane El Mezouar, Nessrine Akasbi, Taoufik Harzy   +3 more
openalex   +2 more sources